Christine Brideau

Christine Brideau is a Vice President, Preclinical Pharmacology, Deerfield Discovery and Development, and joined the Firm in 2019. Prior to Deerfield, Ms. Brideau was Vice President of In Vitro Pharmacology at WuXi AppTec and led the development of WuXi’s US-based in vitro biology unit in New Jersey. Before WuXi, Ms. Brideau spent 24 years at Merck, where she most recently served as Executive Director of In Vitro Pharmacology and supported multiple drug discovery projects from hit-to-lead to clinical candidate. She is the co-author of more than 40 peer-reviewed publications in the areas of pharmacology, assay development, screening day analysis, automation and compound management. Ms. Brideau has served as an editorial board member of SLAS Discovery and as a reviewer for the NIH Molecular Libraries Program study section.